Therapeutic Targets of Monoclonal Antibodies Used in the Treatment of Cancer: Current and Emerging

Cancer is one of the leading global causes of death and disease, and treatment options are constantly evolving. In this sense, the use of monoclonal antibodies (mAbs) in immunotherapy has been considered a fundamental aspect of modern cancer therapy. In order to avoid collateral damage, it is indisp...

Descripción completa

Detalles Bibliográficos
Autores principales: Effer, Brian, Perez, Isabela, Ulloa, Daniel, Mayer, Carolyn, Muñoz, Francisca, Bustos, Diego, Rojas, Claudio, Manterola, Carlos, Vergara-Gómez, Luis, Dappolonnio, Camila, Weber, Helga, Leal, Pamela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377242/
https://www.ncbi.nlm.nih.gov/pubmed/37509725
http://dx.doi.org/10.3390/biomedicines11072086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377242/
https://www.ncbi.nlm.nih.gov/pubmed/37509725
http://dx.doi.org/10.3390/biomedicines11072086

Ejemplares similares